Reklaim Ltd. Reports Q3 2026 Revenue of $3.16 Million, Up 187%, and Net Income of $1.27 Million

(TSXV: MYID) (OTCQB: MYIDF) Reklaim Ltd. reported financial results for the three and nine months ended September 30, 2026. Reklaim generated quarterly revenue of $3,156,313, representing an increase of 187.1% from Q3 2025 and 19.9% from Q2 2026. Net income for the quarter reached $1,272,063, up 76.0% from the second quarter and compared with a net loss of $514,636 in the prior-year period. Gross profit increased 36.5% sequentially to $2,752,814, while gross margin expanded to 87.2% from 76.6%. Operating expenses increased 15.7% over Q2. During Q3 2026, Reklaim repurchased 5,149,000 common shares under its Normal Course Issuer Bid (NCIB), bringing total repurchases for the first nine months of 2026 to 11,275,000 common shares. On October 5, 2026, the company cancelled the 5,149,000 shares repurchased during Q3, bringing total cancellations to 11,275,000 common shares. For the first nine months of 2026, Reklaim generated $7,592,647 in revenue, $2,359,914 in net income, and $1,733,522 in cash from operating activities. Q3 2026 revenue increased 187.1% to $3,156,313 from $1,099,363 in Q3 2025. Gross profit increased 232.8% to $2,752,814 from $827,259 in Q3 2025. Gross margin expanded to 87.2%, compared with 75.3% in Q3 2025 and 76.6% in Q2 2026. Operating expenses totalled $1,506,070, an increase of 12.2% from $1,342,472 in Q3 2025. Net income was $1,272,063, compared with a net loss of $514,636 in Q3 2025, marking Reklaim's third consecutive profitable quarter. Reklaim upgraded its U.S. trading market from OTC Pink to the OTCQB Venture Market, increasing visibility among U.S. investors and supporting efforts to broaden its shareholder base. Reklaim's U.S. trading symbol, MYIDF, remains unchanged. Readers are advised to review these results together with Reklaim's unaudited interim consolidated financial statements and accompanying notes, and its MD&A for the three and nine months ended September 30, 2026.

Reklaim Ltd. Announces Proposed Amendment to Convertible Debentures

(TSXV:MYID) (OTCQB:MYIDF) Reklaim Ltd. announced proposed amendments to its outstanding convertible debentures to allow holders to voluntarily convert all or a portion of their principal into common shares before maturity, subject to TSX Venture Exchange (TSXV) approval and the company entering into amending agreements with the applicable debenture holders. The company intends to file an application with the TSXV to amend certain terms of its 12% senior secured convertible debentures, which have an aggregate principal amount of $500,000 and were issued on October 29, 2025, as part of a non-brokered private placement. Under the current terms, each debenture holder may convert the outstanding principal into common shares at a conversion price of $0.105 per share on October 29, 2028, the maturity date. The proposed amendments would permit each debenture holder, at any time and from time to time before the maturity date, to convert all or any portion of the outstanding principal into shares at the same conversion price. To effect an early conversion, a debenture holder must deliver a written conversion notice to the company. Accrued interest on the converted principal will be calculated to the conversion date and paid on the next interest payment date, with no further interest accruing on that principal after conversion. Any principal not converted will remain outstanding, continue to bear interest at 12% per annum, and remain secured under the existing security agreement. A debenture holder may not convert principal if, after conversion, they and any person acting jointly or in concert would beneficially own or control 20% or more of the issued and outstanding shares, unless the company first obtains any required shareholder approval under TSXV policies. The amendments relate solely to permitting voluntary conversion before maturity; all other terms, including principal amount, interest rate, interest payment provisions, maturity date, security, and early repayment rights, remain unchanged. The terms of the warrants issued with the debentures also remain unchanged. Debenture holders who do not elect early conversion will retain their debentures under the existing terms. The amendments are subject to TSXV approval and the company entering into amending agreements with the applicable debenture holders.

Reklaim Ltd Reports Q2 2026 Results: Revenue Up 103%, Net Income of $723,000

(TSXV: MYID) (OTC: MYIDF) Reklaim Ltd. reported financial results for the three months ended June 30, 2026, including revenue of $2.63 million, representing 102.7% year-over-year growth, and net income of $722,954. For the first six months of 2026, Reklaim generated $4.44 million in revenue and $1.09 million in net income. During the same period, the Company repurchased and returned to treasury 6.126 million common shares under its Normal Course Issuer Bid ("NCIB"). Revenue increased 102.7% to $2,632,143 compared to $1,298,703 in Q2-2025. Gross profit increased 101.4% to $2,017,241 compared to $1,001,583 in Q2-2025. Gross margin was 76.6%. Operating cash flow for the first half of 2026 was approximately $849,532.

Reklaim Ltd Reports 2025 Year-End Results Highlighting Strategic Investment Phase and Q4 Operational Improvement

Reklaim Ltd. (TSXV: MYID, OTC: MYIDF) reported its financial results for the year ended December 31, 2025, highlighting a deliberate mid-year investment in AI product development and commercial infrastructure. Revenue for 2025 totaled $4,992,060, a 2% decrease from 2024, while gross margins remained strong at 78%. The company posted a net loss of $1,007,022 compared to net income of $373,353 in the prior year, primarily due to increased operating expenses from targeted investments. Fourth-quarter results showed improvement, with revenue rising to $1,331,803 and net loss narrowing to $(91,835). Reklaim ended the year with $472,296 in cash and a 27.6% year-over-year decrease in total financial liabilities.